Further, we identify NNMT as biomarker for poor prognosis, and verify that NNMT overexpression mediated homocysteine metabolism dysregulation is a potential therapeutic opportunity for renal cell carcinoma. The gene discussed is NNMT; the disease is hereditary clear cell renal cell carcinoma.